Home

Panacea Biotec Ltd PE Ratio

Image

Panacea Biotec Ltd

NSE: PANACEABIO

PE

-

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Panacea Biotec Ltd is 0 as of 15 Jan 09:56 AM .
  • The P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of Panacea Biotec Ltd is ₹ 407.4 as of 15 Jan 09:50 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Panacea Biotec Ltd

No data available

Company Fundamentals for Panacea Biotec Ltd

Image

Panacea Biotec Ltd

NSE: PANACEABIO

Share Price

₹ 407.4

-7.75 (-1.87%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Panacea Biotec Ltd

1M

1Y

3Y

5Y

Monitoring Panacea Biotec Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025415.15
13 Jan 2025418.85
10 Jan 2025433.85
09 Jan 2025440.3
08 Jan 2025448.9
07 Jan 2025448.5
06 Jan 2025443.85
03 Jan 2025442.85
02 Jan 2025429.4
01 Jan 2025438.5

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Panacea Biotec Ltd

Asset Value vs Market Value of Panacea Biotec Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Panacea Biotec Ltd2542
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Panacea Biotec Ltd Explained

``

2542

Market cap

-15

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Panacea Biotec Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Panacea Biotec Ltd

No data available

* All values are in %

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Panacea Biotec Ltd News Hub

Panacea Biotec reports consolidated net loss of Rs 15.88 crore in the June 2024 quarter

Net loss of Panacea Biotec reported to Rs 15.88 crore in the quarter ended June 2024 as against net

Read more

2024-08-14 00:00:00

Panacea Biotec reports standalone net loss of Rs 13.78 crore in the June 2024 quarter

Net loss of Panacea Biotec reported to Rs 13.78 crore in the quarter ended June 2024 as against net

Read more

2024-08-14 00:00:00

Panacea Biotec announces board meeting date

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 August 2024. Power

Read more

2024-08-07 00:00:00

Panacea Biotec to hold AGM

Panacea Biotec announced that the Annual General Meeting (AGM) of the company will be held on 27 Sep

Read more

2024-09-18 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Panacea Biotec Ltd

What is the current PE Ratio of Panacea Biotec Ltd?

The Current PE Ratio of Panacea Biotec Ltd is 0.0 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Panacea Biotec Ltd last year?

The PE Ratio of Panacea Biotec Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Panacea Biotec Ltd indicate about its stock?

The PE Ratio of Panacea Biotec Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Panacea Biotec Ltd.

What is the PE Ratio Growth of Panacea Biotec Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Panacea Biotec Ltd grew by -% whereas, the EPS ratio grew by -129.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions